Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
Félix Ratjen(Hospital for Sick Children), L. Bendy, George Retsch‐Bogart(University of North Carolina at Chapel Hill), Danielle Goetz(University at Buffalo, State University of New York), Sanja Stanojevic(Dalhousie University), Laura Raterman, Beth Cahill, Carol Kopecky, Ashlee Parsons, Gary L. McPhail, Nadine Caci, Patti Olson, Nicoline Schaap, Kelly Thornton(Texas State University), Britany Zeglin, Monica Ulles, Henry L. Dorkin(Boston Children's Hospital), Steven Ward, Charles Clem(Riley Hospital for Children), Richard A. Kronmal(University of Washington), Brittany Consiglio, Gwen Kerby, Heather Hathorne, Meg Anthony, Karen McCoy(Nationwide Children's Hospital), Karen Hinckley Stukovsky(University of Washington), James F. Chmiel(Riley Hospital for Children), Peter Hiatt, Stephanie D. Davis(University of North Carolina at Chapel Hill), Heather Tribout, Neal W. Jorgensen(Mayo Clinic), Terri Johnson, Margaret Rosenfeld(Seattle Children's Hospital), Katie Slaten, Susanna A. McColley(Northwestern University), Peter J. Mogayzel(Johns Hopkins University), Cindy Schaefer, Emily Bell(Duke University Health System), Doug Walker, Cole Fenton, Betty F Walker, Miriam Davis(Riley Hospital for Children), Wynton Hoover, Robert Fowler, Kimberly Keller, C. Roach, Rose Cunnion(Seattle Children's Hospital), Robin Johnson, Megan Tribout
Cited by 115
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
|New England Journal of Medicine|2011|870
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
|New England Journal of Medicine|1993|458